TEVA PHARMACEUTICAL INDUSTRIES LIMITED Current Assets
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) had Current Assets of $13.76 billion as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-07-29
- 2026-06-30: Assets, Current $13.76B.
- 2026-03-31: Assets, Current $13.71B.
- 2025-12-31: Assets, Current $13.95B.
- 2025-09-30: Assets, Current $12.74B.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $13.76B 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $13.71B 10-Q · filed 2026-04-29 | |
| 2025-12-31 | $13.95B 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $12.74B 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $12.62B 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $11.53B 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $12.55B 10-K · filed 2026-02-03 | |
| 2024-09-30 | $12.31B 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $11.63B 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $12.30B 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $12.48B 10-K · filed 2025-02-05 | |
| 2023-09-30 | $11.43B 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $12.09B 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $11.50B 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $12.05B 10-K · filed 2024-02-12 | |
| 2022-09-30 | $11.45B 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $12.16B 10-Q · filed 2022-07-27 | |
| 2022-03-31 | $12.45B 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $12.57B 10-K · filed 2023-02-10 | |
| 2021-09-30 | $12.15B 10-Q · filed 2021-10-27 | |
| 2021-06-30 | $12.82B 10-Q · filed 2021-07-28 | |
| 2021-03-31 | $12.40B 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $13.01B 10-K · filed 2022-02-09 | |
| 2020-09-30 | $12.16B 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $12.78B 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $12.88B 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $13.46B 10-K · filed 2021-02-10 | |
| 2019-09-30 | $12.54B 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $13.80B 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $13.43B 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $13.79B 10-K · filed 2020-02-21 | |
| 2018-09-30 | $13.88B 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $14.71B 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $14.69B 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $15.38B 10-K · filed 2019-02-19 | |
| 2017-09-30 | $16.23B 6-K · filed 2017-11-02 | |
| 2017-06-30 | $14.60B 6-K · filed 2017-08-03 | |
| 2017-03-31 | $14.84B 6-K · filed 2017-05-11 | |
| 2016-12-31 | $17.23B 10-K · filed 2018-02-12 | $16.96B 20-F · filed 2017-02-15 |
| 2016-09-30 | $17.39B 6-K · filed 2016-11-15 | |
| 2016-06-30 | $18.34B 6-K · filed 2016-08-04 | |
| 2016-03-31 | $16.99B 6-K · filed 2016-05-09 | |
| 2015-12-31 | $18.40B 20-F · filed 2017-02-15 | |
| 2015-09-30 | $12.50B 6-K · filed 2015-10-29 | |
| 2015-06-30 | $13.30B 6-K · filed 2015-07-30 | |
| 2015-03-31 | $15.71B 6-K · filed 2015-04-30 | |
| 2014-12-31 | $14.40B 20-F · filed 2016-02-11 | |
| 2014-09-30 | $13.92B 6-K · filed 2014-10-30 | |
| 2014-06-30 | $13.55B 6-K · filed 2014-07-31 | |
| 2014-03-31 | $13.45B 6-K · filed 2014-05-02 | |
| 2013-12-31 | $13.72B 20-F · filed 2015-02-09 | |
| 2013-09-30 | $13.91B 6-K · filed 2013-10-31 | |
| 2013-06-30 | $14.09B 6-K · filed 2013-08-01 | |
| 2013-03-31 | $14.42B 6-K · filed 2013-05-02 | |
| 2012-12-31 | $16.36B 20-F · filed 2014-02-10 | |
| 2012-09-30 | $14.98B 6-K · filed 2012-11-01 | |
| 2012-06-30 | $14.22B 6-K · filed 2012-08-02 | |
| 2012-03-31 | $14.97B 6-K · filed 2012-05-09 | |
| 2011-12-31 | $14.45B 20-F · filed 2013-02-12 | |
| 2011-09-30 | $13.02B 6-K · filed 2011-11-02 | |
| 2011-06-30 | $12.60B 6-K · filed 2011-07-28 | |
| 2011-03-31 | $12.05B 6-K · filed 2011-05-11 | |
| 2010-12-31 | $12.04B 20-F · filed 2012-02-17 | |
| 2010-09-30 | $11.86B 6-K · filed 2010-11-02 | |
| 2010-06-30 | $14.44B 6-K · filed 2010-07-27 | |
| 2010-03-31 | $12.61B 6-K · filed 2010-05-04 | |
| 2009-12-31 | $12.04B 20-F · filed 2011-02-15 | $12.14B 20-F · filed 2010-02-22 |
| 2009-09-30 | $11.46B 6-K · filed 2009-11-03 | |
| 2009-06-30 | $11.04B 6-K · filed 2009-07-29 | |
| 2009-03-31 | $11.14B 6-K · filed 2009-05-07 | |
| 2008-12-31 | $11.43B 20-F · filed 2010-02-22 |